0001662118-19-000002.txt : 20190801 0001662118-19-000002.hdr.sgml : 20190801 20190801135633 ACCESSION NUMBER: 0001662118-19-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190801 DATE AS OF CHANGE: 20190801 EFFECTIVENESS DATE: 20190801 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Petra Pharma Corp CENTRAL INDEX KEY: 0001662118 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-321233 FILM NUMBER: 19992125 BUSINESS ADDRESS: STREET 1: 430 EAST 29TH STREET CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: (206) 957-7300 MAIL ADDRESS: STREET 1: 430 EAST 29TH STREET CITY: NEW YORK STATE: NY ZIP: 10016 D/A 1 primary_doc.xml X0708 D/A LIVE 0001662118 Petra Pharma Corp 450 E 29th St., Suite 506 NEW YORK NY NEW YORK 10016 (206) 957-7300 DELAWARE None None Corporation true 2015 Thong Le c/o Petra Pharma Corporation 450 E 29th St., Suite 506 New York NY NEW YORK 10016 Director Promoter Steve Gillis c/o Petra Pharma Corporation 450 E 29th St., Suite 506 New York NY NEW YORK 10016 Director M. Johnston Erwin c/o Petra Pharma Corporation 450 E 29th St., Suite 506 New York NY NEW YORK 10016 Director Barbara Dalton c/o Petra Pharma Corporation 450 E 29th St., Suite 506 New York NY NEW YORK 10016 Director Jenna Foger c/o Petra Pharma Corporation 450 E 29th St., Suite 506 New York NY NEW YORK 10016 Director Paul Sekhri c/o Petra Pharma Corporation 450 E 29th St., Suite 506 New York NY NEW YORK 10016 Director Brian O'Callaghan c/o Petra Pharma Corporation 450 E 29th St., Suite 506 New York NY NEW YORK 10016 Executive Officer Director David McElligott c/o Petra Pharma Corporation 450 E 29th St., Suite 506 New York NY NEW YORK 10016 Executive Officer Promoter David Renas c/o Petra Pharma Corporation 450 E 29th St., Suite 506 New York NY NEW YORK 10016 Executive Officer Albert Yu c/o Petra Pharma Corporation 450 E 29th St., Suite 506 New York NY NEW YORK 10016 Executive Officer Lindsay Rayle c/o Petra Pharma Corporation 450 E 29th St., Suite 506 New York NY NEW YORK 10016 Promoter David Schubert c/o Petra Pharma Corporation 450 E 29th St., Suite 506 New York NY NEW YORK 10016 Promoter Biotechnology Decline to Disclose 06b true 0001662118-19-000001 2018-08-30 false true true true false 0 17045484 17045484 0 false 10 0 0 0 false Petra Pharma Corp /s/ David Renas David Renas Chief Financial Officer 2019-08-01